Avadel Pharmaceuticals (AVDL) Change in Account Payables (2016 - 2022)
Historic Change in Account Payables for Avadel Pharmaceuticals (AVDL) over the last 10 years, with Q4 2022 value amounting to $8.5 million.
- Avadel Pharmaceuticals' Change in Account Payables rose 9221.75% to $8.5 million in Q4 2022 from the same period last year, while for Dec 2022 it was -$3.1 million, marking a year-over-year decrease of 17344.05%. This contributed to the annual value of -$4.1 million for FY2024, which is 36491.91% down from last year.
- Latest data reveals that Avadel Pharmaceuticals reported Change in Account Payables of $8.5 million as of Q4 2022, which was up 9221.75% from -$7.2 million recorded in Q3 2022.
- Avadel Pharmaceuticals' Change in Account Payables' 5-year high stood at $8.5 million during Q4 2022, with a 5-year trough of -$7.2 million in Q3 2022.
- Moreover, its 5-year median value for Change in Account Payables was -$370000.0 (2020), whereas its average is $47250.0.
- As far as peak fluctuations go, Avadel Pharmaceuticals' Change in Account Payables crashed by 293540.67% in 2018, and later skyrocketed by 119228.65% in 2021.
- Quarter analysis of 5 years shows Avadel Pharmaceuticals' Change in Account Payables stood at -$6.3 million in 2018, then surged by 169.07% to $4.4 million in 2019, then tumbled by 71.18% to $1.3 million in 2020, then soared by 250.99% to $4.4 million in 2021, then surged by 92.22% to $8.5 million in 2022.
- Its last three reported values are $8.5 million in Q4 2022, -$7.2 million for Q3 2022, and $1.2 million during Q2 2022.